On August 4, Medline Inc rose 4.05% in regular trading, trading at $42.16/share, with turnover of approximately $207 million.

On the news front, the company is scheduled to release its second-quarter fiscal results on August 5 before market open, and investor sentiment has been bolstered by a strong first-quarter performance. In Q1, Medline reported EPS of $0.33, beating the consensus estimate of $0.23 by over 43%, while revenue of $7.4 billion also surpassed the $7.163 billion estimate. For Q2, consensus expectations call for revenue of approximately $7.518 billion and adjusted EPS of $0.32.

Additionally, the company announced a Prime Vendor Agreement with Allina Health in July, a healthcare system serving communities in Minnesota and western Wisconsin, further expanding its distribution network. Medline also launched its AI-powered Mpower supply chain platform earlier this year, which showed more than a 50% improvement in order substitution workflows across initial deployments at 10 US health systems.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)